Supernus Pharmaceuticals said it is acquiring Sage Therapeutics, the distressed maker of a drug for postpartum depression, ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

The links between ultra-processed food and higher risk of diabetes will be the focus of the first wave of Kennedy’s national ...

An IVF doctor and clinic founder writes that his industry needs increased governmental oversight and more comprehensive ...

The law shouldn’t force pregnant people to assume greater duties to their fetuses than parents have to their children.

To prevent ovarian cancers, fallopian tube removal is on an upsurge — and diagnostic manuals are finally catching up.

Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death ...

To finance tax cuts, a GOP bill would reduce Medicaid payments to hospitals by $321 billion, hitting both blue and red states ...

Me, which became a household name for its genetic testing services, is set to emerge from bankruptcy as a nonprofit.

Hospitals, physician groups, and nursing homes across 15 states will receive billions of dollars in extra Medicaid funding ...

Exclusive: Facing NIH cuts in "indirect cost" funding, universities float new models to streamline requests and ensure ...

The entanglements and strongly expressed views of the new vaccine panel raises questions of how Robert F. Kennedy Jr. defines ...